ECSP024345A - Proteina asociada con enfermedad - Google Patents
Proteina asociada con enfermedadInfo
- Publication number
- ECSP024345A ECSP024345A EC2002004345A ECSP024345A ECSP024345A EC SP024345 A ECSP024345 A EC SP024345A EC 2002004345 A EC2002004345 A EC 2002004345A EC SP024345 A ECSP024345 A EC SP024345A EC SP024345 A ECSP024345 A EC SP024345A
- Authority
- EC
- Ecuador
- Prior art keywords
- syndrome
- disease
- protein
- aging
- methods
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 title abstract 3
- 108090000623 proteins and genes Proteins 0.000 title abstract 3
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 208000032430 Retinal dystrophy Diseases 0.000 abstract 3
- 208000011580 syndromic disease Diseases 0.000 abstract 3
- 208000032578 Inherited retinal disease Diseases 0.000 abstract 2
- 230000032683 aging Effects 0.000 abstract 2
- 201000006321 fundus dystrophy Diseases 0.000 abstract 2
- 208000017532 inherited retinal dystrophy Diseases 0.000 abstract 2
- 208000002780 macular degeneration Diseases 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 206010010356 Congenital anomaly Diseases 0.000 abstract 1
- 206010025412 Macular dystrophy congenital Diseases 0.000 abstract 1
- 208000027073 Stargardt disease Diseases 0.000 abstract 1
- 208000014769 Usher Syndromes Diseases 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000012544 monitoring process Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
- 201000007790 vitelliform macular dystrophy Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Marine Sciences & Fisheries (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Ophthalmology & Optometry (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0104712A FR2823221B1 (fr) | 2001-04-06 | 2001-04-06 | Sequences associees a la degenerescence retinienne et applications |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP024345A true ECSP024345A (es) | 2004-06-28 |
Family
ID=8862037
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EC2002004345A ECSP024345A (es) | 2001-04-06 | 2002-11-19 | Proteina asociada con enfermedad |
Country Status (22)
| Country | Link |
|---|---|
| US (6) | US7795387B2 (enExample) |
| EP (1) | EP1379657B1 (enExample) |
| JP (2) | JP4370428B2 (enExample) |
| KR (1) | KR100913258B1 (enExample) |
| CN (1) | CN1529753B (enExample) |
| AU (1) | AU2002312794B8 (enExample) |
| BR (1) | BRPI0208870B8 (enExample) |
| CA (1) | CA2443345C (enExample) |
| CZ (1) | CZ305800B6 (enExample) |
| EC (1) | ECSP024345A (enExample) |
| ES (1) | ES2597835T3 (enExample) |
| FR (1) | FR2823221B1 (enExample) |
| HU (1) | HU226307B1 (enExample) |
| IL (3) | IL158013A0 (enExample) |
| MX (1) | MXPA03009114A (enExample) |
| NO (1) | NO331277B1 (enExample) |
| NZ (1) | NZ528376A (enExample) |
| PL (1) | PL213658B1 (enExample) |
| RU (1) | RU2384586C2 (enExample) |
| SK (1) | SK288465B6 (enExample) |
| WO (1) | WO2002081513A2 (enExample) |
| ZA (1) | ZA200307403B (enExample) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2823221B1 (fr) | 2001-04-06 | 2004-04-02 | Univ Pasteur | Sequences associees a la degenerescence retinienne et applications |
| US7261544B2 (en) | 2003-05-21 | 2007-08-28 | Genzyme Corporation | Methods for producing preparations of recombinant AAV virions substantially free of empty capsids |
| FR2870241B1 (fr) * | 2004-05-13 | 2015-02-27 | Novartis Ag | Facteur de viabilite des cones derive des batonnets ou rdcvf et applications |
| EP2027889A1 (en) * | 2007-06-05 | 2009-02-25 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | New neuronal viability factor and use thereof |
| EP2281047B1 (en) | 2008-04-15 | 2020-04-08 | Genzyme Corporation | Methods to produce rod-derived cone viability factor (rdcvf) |
| JP5748223B2 (ja) * | 2008-09-10 | 2015-07-15 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | ニューロン生存因子およびその使用 |
| EP2383286A1 (en) | 2010-04-30 | 2011-11-02 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and compositions for treatment of retinal degenerative diseases |
| BR112014010091B1 (pt) | 2011-10-27 | 2022-11-08 | Wellstat Ophthalmics Corporation | Ácido nucleico, vetor viral, preparação farmacêutica, uso destes, método para produção de uma proteína rdcvf, e método in vitro ou ex vivo de secreção de uma proteína rdcvf a partir de uma célula |
| US20150038557A1 (en) | 2012-02-24 | 2015-02-05 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Methods and compositions for treatment of retinal degenerative diseases |
| US10004780B2 (en) | 2012-10-17 | 2018-06-26 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for the treatment of age-related macular degeneration (AMD) |
| EP3027646B1 (en) | 2013-07-31 | 2018-06-27 | Novartis AG | Novel selection vectors and methods of selecting eukaryotic host cells |
| JP6684343B2 (ja) | 2015-05-21 | 2020-04-22 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | ニューロン生存因子の相乗組み合わせ及びその使用 |
| US10857240B2 (en) | 2016-01-05 | 2020-12-08 | The Trustees Of The University Of Pennsylvania | Methods and compositions for treatment of ocular disorders and blinding diseases |
| GB201603987D0 (en) | 2016-03-08 | 2016-04-20 | Immatics Biotechnologies Gmbh | Uterine cancer treatments |
| BR112018076674A2 (pt) * | 2016-10-11 | 2019-04-02 | Wellstat Ophthalmics Corporation | proteína de fusão entre o fator de viabilidade do cone derivado de bastonetes de forma curta e um peptídeo hidrofílico |
| US20230146121A1 (en) * | 2019-12-09 | 2023-05-11 | Chigenovo Co., Ltd. | Use of cyp4v2 and rdcvf in the manufacture of medicament |
| CN111733174B (zh) * | 2020-08-07 | 2021-02-09 | 北京大学第三医院（北京大学第三临床医学院） | 一种分离的核酸分子及其用途 |
| EP4366757A1 (en) * | 2021-07-07 | 2024-05-15 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Synergistic combination of rdcfv2 and rdcvf2l for the treatment of tauopathies |
| CN113774019B (zh) * | 2021-08-11 | 2024-02-13 | 东南大学 | 一种脐带血间充质干细胞无血清培养基、培养方法及其应用 |
| US20240342313A1 (en) | 2023-03-30 | 2024-10-17 | Pharma Cinq, Llc | Vector encoding rod-derived cone viability factor and human igk signal sequence |
| US20260091133A1 (en) | 2024-09-27 | 2026-04-02 | Pharma Cinq, Llc | Rod-derived cone viability factor fusion protein |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4771036A (en) | 1986-02-10 | 1988-09-13 | Trustees Of Columbia University In The City Of New York | Method and ophthalmic composition for the prevention and reversal of cataracts |
| GB9701710D0 (en) * | 1997-01-28 | 1997-03-19 | Karobio Ab | Mammalian protein |
| US6106825A (en) * | 1997-05-07 | 2000-08-22 | University Of Florida | Entomopoxvirus-vertebrate gene delivery vector and method |
| FR2784030B1 (fr) | 1998-10-02 | 2002-12-20 | Inst Nat Sante Rech Med | Utilisation de bloqueurs des canaux calciques et/ou cgmp-dependants pour le traitement de pathologies de la retine |
| FR2784898A1 (fr) | 1998-10-26 | 2000-04-28 | Univ Pasteur | Utilisation du gdnf pour le traitement de la degenerescence retinienne |
| EP1033405A3 (en) * | 1999-02-25 | 2001-08-01 | Ceres Incorporated | Sequence-determined DNA fragments and corresponding polypeptides encoded thereby |
| EP1242443A4 (en) * | 1999-12-23 | 2005-06-22 | Nuvelo Inc | NEW NUCLEIC ACIDS AND POLYPEPTIDES |
| FR2823221B1 (fr) | 2001-04-06 | 2004-04-02 | Univ Pasteur | Sequences associees a la degenerescence retinienne et applications |
| US20060275794A1 (en) | 2005-03-07 | 2006-12-07 | Invitrogen Corporation | Collections of matched biological reagents and methods for identifying matched reagents |
| JP5748223B2 (ja) | 2008-09-10 | 2015-07-15 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | ニューロン生存因子およびその使用 |
-
2001
- 2001-04-06 FR FR0104712A patent/FR2823221B1/fr not_active Expired - Lifetime
-
2002
- 2002-04-05 CN CN028094700A patent/CN1529753B/zh not_active Expired - Lifetime
- 2002-04-05 US US10/473,008 patent/US7795387B2/en not_active Expired - Lifetime
- 2002-04-05 HU HU0303730A patent/HU226307B1/hu unknown
- 2002-04-05 CA CA2443345A patent/CA2443345C/en not_active Expired - Lifetime
- 2002-04-05 EP EP02737923.9A patent/EP1379657B1/en not_active Expired - Lifetime
- 2002-04-05 PL PL364681A patent/PL213658B1/pl unknown
- 2002-04-05 AU AU2002312794A patent/AU2002312794B8/en not_active Expired
- 2002-04-05 MX MXPA03009114A patent/MXPA03009114A/es active IP Right Grant
- 2002-04-05 KR KR1020037012934A patent/KR100913258B1/ko not_active Expired - Lifetime
- 2002-04-05 RU RU2003130638/13A patent/RU2384586C2/ru active
- 2002-04-05 JP JP2002579898A patent/JP4370428B2/ja not_active Expired - Lifetime
- 2002-04-05 ES ES02737923.9T patent/ES2597835T3/es not_active Expired - Lifetime
- 2002-04-05 NZ NZ528376A patent/NZ528376A/en not_active IP Right Cessation
- 2002-04-05 CZ CZ2003-2706A patent/CZ305800B6/cs not_active IP Right Cessation
- 2002-04-05 WO PCT/EP2002/003810 patent/WO2002081513A2/en not_active Ceased
- 2002-04-05 SK SK1223-2003A patent/SK288465B6/sk unknown
- 2002-04-05 IL IL15801302A patent/IL158013A0/xx unknown
- 2002-04-05 BR BRPI0208870A patent/BRPI0208870B8/pt not_active IP Right Cessation
- 2002-11-19 EC EC2002004345A patent/ECSP024345A/es unknown
-
2003
- 2003-09-18 IL IL158013A patent/IL158013A/en unknown
- 2003-09-23 ZA ZA200307403A patent/ZA200307403B/en unknown
- 2003-10-03 NO NO20034452A patent/NO331277B1/no not_active IP Right Cessation
-
2007
- 2007-04-25 US US11/739,734 patent/US8071745B2/en not_active Expired - Fee Related
- 2007-04-25 US US11/739,739 patent/US8114849B2/en not_active Expired - Fee Related
-
2009
- 2009-03-04 JP JP2009050689A patent/JP4571695B2/ja not_active Expired - Lifetime
- 2009-06-11 IL IL199316A patent/IL199316A/en active IP Right Grant
-
2012
- 2012-01-11 US US13/348,435 patent/US8518695B2/en not_active Expired - Fee Related
- 2012-01-11 US US13/348,383 patent/US8394756B2/en not_active Expired - Fee Related
-
2013
- 2013-06-04 US US13/909,764 patent/US8957043B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2004075823A3 (fr) | Derives de benzimidazole et d’imidazo-pyridine ayant une addinite pour les recepteurs des melanocortines et leur utilisation en tant que medicament | |
| WO2005055945A3 (en) | Mucoadhesive drug delivery devices and methods of making and using thereof | |
| NO20034452D0 (no) | Sykdomsassosiert protein | |
| NO20081124L (no) | Anti-CD 3 antistoff-formuleringer | |
| CL2011000867A1 (es) | Formas cristalinas da, c y ii de (r)-5-[3-cloro-4-(2,3-dihidroxi-propoxi)- benz[z]ilideno]-2- ([z]- propilimino) -3-o- totil-tiazolidin-4-ona; composicion farmaceutica; y uso en el tratamiento o prevencion de rechazo de organos trasplantados, sindrome autoinmunitarios, asma, diabetes, cancer. | |
| WO2010085100A3 (ko) | 신규한 세포막 투과 도메인 및 이를 포함하는 세포내 전달 시스템 | |
| PA8477801A1 (es) | (3s) tetrahidro-3-furanil (1s,2r)-3-[[4-aminofenil) sulfonil)] (isobutil) amino]-1-bencil-2-(fosfonooxi) propilcarbamato de calcio | |
| WO2008048288A3 (en) | Novel nanoparticles and use thereof | |
| CY1112981T1 (el) | Μεθοδος και συνθεση για την αγωγη της ρινιτιδας | |
| WO2008148573A3 (de) | Arzeimittel mit einer wirkstoffkombination enthaltend pantothensäure oder deren derivate zur behandlung von allergischen symptomen | |
| CL2004000710A1 (es) | Composicion antimicrobiana y antiparasitaria formada por un antibiotico derivado del cloranfenicol o tianfenicol, un endectocida y por lo menos un vehiculo aceptable, y su uso para tratar enfermedades respiratorias y parasitarias de los bovinos. | |
| BRPI0408889A (pt) | uso de clusterina para o tratamento e/ou prevenção de doenças neurológicas periféricas | |
| WO2007130509A3 (en) | Pyrroloquinoline quinones and use thereof | |
| NO20076663L (no) | Immunoglobuliner | |
| NO20054180D0 (no) | Behandling av bakterielle sykdommer i andedrettsorganene ved lokal tilforsel av fluorkinoloner | |
| NO20054535L (no) | Bifunksjonelle heterocykliske forbindelser og fremgangsmater for fremstilling og anvendelse av samme | |
| TW200511999A (en) | Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and parathyroid hormone | |
| TWI347845B (en) | Pharmaceutical compositions,combinations,and kits for the treatment of respiratory diseases and use of the same | |
| UA107177C2 (uk) | Імуногенна композиція цвс2 та спосіб приготування такої композиції | |
| WO2006002846A3 (en) | New analogs of nitrobenzylthioinosine | |
| WO2005107871A3 (en) | Pyrroloquinoline quinone drugs for treatment of cardiac injury | |
| IL175237A0 (en) | Pentafluorosulfanyl benzoylguanidines, method for their production, their use as medicaments or diagnostic agents and medicament containing the same | |
| WO2006125818A3 (en) | Oral pharmaceutical formulation for the prevention and/or the treatment of cardiovascular and inflammatory diseases | |
| WO2006090365A3 (en) | Polysaccharide-oligoamine conjugates as anti-amyloid and anti-viral agents | |
| NO20060229L (no) | Gaboxadol for behandling av depresjon og andre affektive lidelser |